Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
(NASDAQ: TRAW) Delayed: 0.84 -0.05 (5.62%)
Previous Close $0.89    52 Week High $ 
Open $0.87    52 Week Low $ 
Day High $0.95    P/E N/A 
Day Low $0.84    EPS $ 
Volume 262,224